If you need an accessible version of this item please contact JSTOR User Support

Use of a Structured Panel Process to Define Quality Metrics for Antimicrobial Stewardship Programs

Andrew M. Morris MD SM, Stacey Brener BSc, Linda Dresser PharmD, Nick Daneman MD MSc, Timothy H. Dellit MD, Edina Avdic PharmD MBA and Chaim M. Bell MD PhD
Infection Control and Hospital Epidemiology
Vol. 33, No. 5 (May 2012), pp. 500-506
DOI: 10.1086/665324
Stable URL: http://www.jstor.org/stable/10.1086/665324
Page Count: 7
  • Download PDF
  • Cite this Item

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support
Use of a Structured Panel Process to Define Quality Metrics for Antimicrobial Stewardship Programs
Preview not available

Abstract

Introduction. Antimicrobial stewardship programs are being implemented in health care to reduce inappropriate antimicrobial use, adverse events, Clostridium difficile infection, and antimicrobial resistance. There is no standardized approach to evaluate the impact of these programs.Objective. To use a structured panel process to define quality improvement metrics for evaluating antimicrobial stewardship programs in hospital settings that also have the potential to be used as part of public reporting efforts.Design. A multiphase modified Delphi technique.Setting. Paper-based survey supplemented with a 1-day consensus meeting.Participants. A 10-member expert panel from Canada and the United States was assembled to evaluate indicators for relevance, effectiveness, and the potential to aid quality improvement efforts.Results. There were a total of 5 final metrics selected by the panel: (1) days of therapy per 1000 patient-days; (2) number of patients with specific organisms that are drug resistant; (3) mortality related to antimicrobial-resistant organisms; (4) conservable days of therapy among patients with community-acquired pneumonia (CAP), skin and soft-tissue infections (SSTI), or sepsis and bloodstream infections (BSI); and (5) unplanned hospital readmission within 30 days after discharge from the hospital in which the most responsible diagnosis was one of CAP, SSTI, sepsis or BSI. The first and second indicators were also identified as useful for accountability purposes, such as public reporting.Conclusion. We have successfully identified 2 measures for public reporting purposes and 5 measures that can be used internally in healthcare settings as quality indicators. These indicators can be implemented across diverse healthcare systems to enable ongoing evaluation of antimicrobial stewardship programs and complement efforts for improved patient safety.

Page Thumbnails